Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of immune protection of SARS-CoV-2 natural infection against reinfection
Hiam Chemaitelly, Nico Nagelkerke, Houssein H. Ayoub, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection
Xun Wang, M Zhang, Kaifeng Wei, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 464-464
Open Access | Times Cited: 3
Protective effect of previous infection and vaccination against reinfection with BA.5 Omicron subvariant: a nationwide population-based study in Japan
Noriko Kitamura, Kanako Otani, Ryo Kinoshita, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 41, pp. 100911-100911
Open Access | Times Cited: 9
History of primary-series and booster vaccination and protection against Omicron reinfection
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 9
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection—Final Update of a Living, Rapid Review
Haley K Holmer, Katherine Mackey, Celia Fiordalisi, et al.
Annals of Internal Medicine (2022) Vol. 176, Iss. 1, pp. 85-91
Open Access | Times Cited: 15
COVID-19 primary series and booster vaccination and potential for immune imprinting
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study
Xiaoju Ma, Zheng Wang, You‐Peng Chen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective
Hiroshi Kusunoki
Pharmacoepidemiology (2023) Vol. 2, Iss. 3, pp. 188-208
Open Access | Times Cited: 7
Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis
Weihua Hu, Huanle Cai, Huan-Chang Yan, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14340-14340
Open Access | Times Cited: 11
Explicit modeling of antibody levels for infectious disease simulations in the context of SARS-CoV-2
Sebastian Alexander Müller, Sydney Paltra, Jakob Rehmann, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107554-107554
Open Access | Times Cited: 6
Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Jeremy Samuel Faust, et al.
BMJ Public Health (2023) Vol. 1, Iss. 1, pp. e000479-e000479
Open Access | Times Cited: 6
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Updated Analysis Involving 22,607 Blood Donors Covering the Period October 2021 to April 2022
Lisa Seekircher, Anita Siller, Manfred Astl, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1877-1877
Open Access | Times Cited: 10
A turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Jeremy Samuel Faust, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 Infection
Yu Kato, Nathaniel I. Bloom, Peifang Sun, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 1, pp. 18-22
Open Access | Times Cited: 8
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta infections
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: An observational study
Suelen H. Qassim, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
Mai Mahmoud, Houssein H. Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 11
Open Access | Times Cited: 4
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
George Kassianos, Pauline MacDonald, Ivan Dinesh Aloysius, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 57-57
Open Access | Times Cited: 1
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity
Marija Vukčević, K. Šerovic, Mateja Despot, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 122-122
Open Access | Times Cited: 1
Symptomatology and IgG Levels Before and After SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals
Nigella M. Paula, Emerson Joucoski, Valter A. Baura, et al.
(2024)
Open Access | Times Cited: 1
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort study
Patrick Brown, Sze Hang Fu, Leslie Newcombe, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Trust Us—We Are the (COVID-19 Misinformation) Experts: A Critical Scoping Review of Expert Meanings of “Misinformation” in the Covid Era
Claudia Chaufan, Natalie Hemsing, Camila Heredia, et al.
COVID (2024) Vol. 4, Iss. 9, pp. 1413-1439
Open Access | Times Cited: 1
Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants
Lu Li, Zhiwei Xie, Youxia Li, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2

Scroll to top